St. Louis Business Journal
April 23, 2010 | Modified: Sunday, April 25, 2010, 6:00am CDT
St. Louis Business Journal - by Evan Binns
Dr. Robert Belshe traveled throughout rural Missouri and Illinois last year to discuss flu vaccines during the H1N1 scare. Drug companies Merck & Co. Inc. and GlaxoSmithKline helped pick up the tab.
Belshe, head of Saint Louis University’s Center for Vaccine Development, spoke at more than 20 educational forums on behalf of the drug companies, and he was paid roughly $18,000 in speaker’s fees and travel expenses, according to the companies’ financial disclosures.
“Companies come to me because I have a deep background in vaccines and because of my training,” Belshe said. “And if I’m available, they compensate me for that.”